View Full Version : Thalidomide approved to treat bone-marrow cancer

06-01-2006, 09:49 AM
Thalidomide approved to treat bone-marrow cancer

WASHINGTON (AP) — Thalidomide received federal approval Thursday for treatment of bone-marrow cancer, marking the further rehabilitation of a drug originally banned more than 40 years ago after it caused thousands of birth defects.

The Food and Drug Administration approved the drug for the treatment of newly diagnosed multiple myeloma, agency spokeswoman Laura Alvey said. Multiple myeloma refers to cancers that affect cells in the bone marrow that are key to fighting infection.

Thalidomide, made by Celgene Corp. of Summit, N.J., and sold as Thalomid, is to be used in treating multiple myeloma in conjunction with dexamethasone, a standard chemotherapy treatment.

link: http://www.usatoday.com/news/health/2006-05-26-bone-marrow-drug_x.htm